HEALTHCARE/PHARMA/TRUMP AS PRESIDENT: "Pharmaceutical executives initially celebrated Donald Trump’s election, expecting the businessman to be friendlier to their industry than Hillary Clinton, a tough critic. But worries about his ire soon set in, and the fears proved justified on Jan. 11 [2017], when Trump said the industry was 'getting away with murder.' His prescription for reducing drug prices: make pharmaceutical companies bid for the government’s business.
The mere threat of Washington using its potentially huge bargaining clout to hold down prices has given the industry a massive headache. Unlike other rich countries, the U.S. doesn’t directly regulate the price of drugs. As a result, Americans spend more on prescription medicines than anyone else."
– “Pharma���s Worst Nightmare,” Bloomberg Magazine, Jan. 23, 2017, Doni Bloomfield, with Hui Li, 1/23/2017